Most are gastrointestinal, including nausea, vomiting, diarrhea, constipation, or abdominal discomfort, but some symptoms may signal dehydration, kidney stress, gallbladder disease, pancreatitis, hypoglycemia, or another problem that requires medical evaluation
Other health conditions, such as obesity, smoking, diabetes, or heart disease, may have contributed
While originally developed for blood sugar management, GLP-1 and GIP therapies are now commonly used under medical supervision to support metabolic health, weight management, and body composition in individuals who meet appropriate criteria
PMID 24843404
Its gaining new attention as a means to combat so-called Ozempic face, the sagging of facial skin thats a common byproduct of rapid weight loss